NDC 53489-355 - Labetalol Hydrochloride
This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.
- Product NDC
- 53489-355
- Package NDCs from labels
- 53489-355-07, 53489-355-06, 53489-355-01, 53489-355-03, 53489-355-05, 53489-355-10
- Manufacturer
- Mutual Pharmaceutical Company, Inc.
- Effective date
- 2007-01-03
- Current FDA listing
- Not matched in FDA.report NDC product tables
DailyMed Labels#
| Label | Manufacturer | Effective date | Type |
|---|---|---|---|
| LABETALOL HYDROCHLORIDE TABLETS, USP | Mutual Pharmaceutical Company, Inc. | 2007-01-03 | HUMAN PRESCRIPTION DRUG LABELING |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 53489-355-01 | Labetalol Hydrochloride | 100 in 1 BOTTLE, PLASTIC | TABLET, FILM COATED | 100 | 1 | |
| 53489-355-03 | Labetalol Hydrochloride | 250 in 1 BOTTLE, PLASTIC | TABLET, FILM COATED | 250 | 1 | |
| 53489-355-05 | Labetalol Hydrochloride | 500 in 1 BOTTLE, PLASTIC | TABLET, FILM COATED | 500 | 1 | |
| 53489-355-06 | Labetalol Hydrochloride | 60 in 1 BOTTLE, PLASTIC | TABLET, FILM COATED | 60 | 1 | |
| 53489-355-07 | Labetalol Hydrochloride | 30 in 1 BOTTLE, PLASTIC | TABLET, FILM COATED | 30 | 1 | |
| 53489-355-10 | Labetalol Hydrochloride | 1000 in 1 BOTTLE, PLASTIC | TABLET, FILM COATED | 1000 | 1 |
DailyMed Dashboard NDC Coverage#
DailyMed Socrata Ingredients#
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| LABETALOL HYDROCHLORIDE | LABETALOL HYDROCHLORIDE | A-S Medication Solutions | 1a71964e-e6fa-443e-bfdd-f8852f8cf29e | 2023-10-26 | Warnings, Adverse reactions | 896762 |
| LABETALOL HYDROCHLORIDE | LABETALOL HYDROCHLORIDE | A-S Medication Solutions | c586ab65-56e8-4a4f-b471-902198d3e58c | 2023-10-17 | Warnings, Adverse reactions | 896758 |
| Labetalol Hydrochloride | LABETALOL HYDROCHLORIDE | Cadila Pharmaceuticals Limited | 5fba93fc-4580-48c2-a1ec-5d446680adcf | 2022-12-09 | Warnings, Adverse reactions | 896766 896758 896762 |
| Labetalol hydrochloride | LABETALOL HYDROCHLORIDE | Proficient Rx LP | c0301841-e209-4242-bace-58a20e6dd01b | 2022-11-01 | Warnings, Adverse reactions | 896758 |
| Labetalol Hydrochloride | LABETALOL HYDROCHLORIDE | Epic Pharma, LLC | b950655d-a9f8-4ace-bb56-0c7abbca231e | 2021-09-30 | Warnings, Adverse reactions | 896766 896758 896762 |
| Labetalol hydrochloride | LABETALOL HYDROCHLORIDE | Actavis Pharma, Inc. | a5b65a9b-6b8a-48a4-9c72-0e605bb309eb | 2015-12-01 | Warnings, Adverse reactions | 896766 896758 896762 |
| B1E6C7AB-EEFE-4089-B403-EDEAAB4F6E36 | B1E6C7AB-EEFE-4089-B403-EDEAAB4F6E36 | 2007-01-03 | Warnings, Adverse reactions | B1E6C7AB-EEFE-4089-B403-EDEAAB4F6E36 B1E6C7AB-EEFE-4089-B403-EDEAAB4F6E36 |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.